Key result
Among 394 acute viral hepatitis cases in Thailand, 39.6% were positive for HAV IgM, with phylogenetic analysis identifying subgenotypes IA and IB circulating in specific provinces.
Observational (n=394)
Yes
This study identifies the circulation of hepatitis A virus subgenotypes IA and IB in Thailand, with genetic segregation closely related to geographic location.
Supports regional HAV surveillance in Thailand; leaves open whether subgenotype data should guide vaccination policy.
Human hepatitis A virus (HAV) is a major causative agent of acute hepatitis, and the isolates are categorised into four genotypes: I (GI), II (GII), III (GIII), and VII (GVII). Although viral hepatitis has been detected under a nationwide surveillance system in Thailand, the genetic variation of HAV has not yet been determined. In the present study, serum specimens were collected from acute hepatitis patients in Thailand from 1998-2002. The IgM-class antibody to HAV was detected in 156 out of 394 sera, counting as many as 39.6% of acute viral hepatitis cases. HAV RNA in the serum specimens was amplified by reverse-transcription polymerase chain reaction (RT-PCR), and a phylogenetic analysis of the putative VP1/2A junction of the genome was performed. The isolates were grouped into two genetic groups, GIA and GIB. This is the first report to identify subgenotype IB (GIB) in Thailand. The genetic segregation was closely related to the province where hepatitis A occurred and the serum specimens were collected. In addition, genetically similar strains were identified in both 1998 and 2001-2002 isolates from two close provinces in the southern part of Thailand, suggesting that a strain indigenous to the province or district has been circulating in southern Thailand.
No takes yet. Share an insight, caveat, or question.
Wattanasri et al. (2004) conducted an observational in Acute hepatitis (n=394). Hepatitis A virus infection was evaluated on IgM-class antibody to HAV. Among 394 acute viral hepatitis cases in Thailand, 39.6% were positive for HAV IgM, with phylogenetic analysis identifying subgenotypes IA and IB circulating in specific provinces.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: